Citichem India Limited IPO Allotment Status
The allotment date for the Citichem India Limited IPO is set for January 1, 2025, with shares priced at a range from ₹ 70 per share and a face value of ₹10. The offering consists of lots of 2000 shares, with bids accepted for these lots or their multiples.
Citichem India Limited IPO Allotment Status Check
To ascertain their allocation status for the Citichem India Limited IPO, investors can easily navigate through steps provided on either the BSE platform or the IPO registrar Kfin Technologies Limited Link.
IPO Allotment Status BSE
Here are steps to check Citichem India Limited IPO allotment status on BSE website
Step 1: Visit BSE website
Step 2: Select ‘Equity’ under the Issue Type
Step 3: Choose Citichem India Limited from the drop-down menu
Step 4: Enter Application No or PAN
Step 5: Click on ‘I am not a Robot’ and then hit on ‘Submit”
Steps to check Citichem India Limited allotment status on Kfin Technologies Limited
Step 1: Visit IPO registrar website – Kfin Technologies Limited
Step 2: Select ‘Citichem India Limited’ from the Select Company dropdown menu
Step 3: Choose from PAN, Application No, DP/Client ID, or Account No/IFSC
Step 4: Enter the details as per the option selected
Step 5: Hit the Submit button
Your Citichem India Limited IPO allotment status will be reflected on the screen.
Citichem India Limited IPO GMP Today
Citichem India Limited IPO GMP (Grey Market Premium) is ₹20 as of December 31, 2024.
Citichem India Limited IPO Subscription Status
Citichem India IPO saw a subscription of 176.57x on its second day, with QIB at 0.00x, NII at 86.42x, and RII showing strong interest with a subscription of 266.29x.
Citichem India Limited IPO Details
Citichem India IPO, a fixed price issue of ₹12.60 crores, offers 18 lakh fresh shares at ₹70 per share. Bidding ran from December 27-31, 2024. Listing on BSE SME is set for January 3, 2025, with Horizon Management as the lead manager and Kfin Technologies as the registrar.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.